Our experienced Ophthalmology Team comprising of ophthalmic experienced clinicians, offer clinical operations and therapeutic focus on all ophthalmic programs. We have extensive experience in planning and implementing Phase I-IV programs for ophthalmology studies across multiple countries and sites We have conducted approximately 20 trials in ophthalmic indications involving more than 8,000 patients and 60+ sites. Our close working relationships with investigators and sites ensure our ability to conduct a preliminary feasibility assessment quickly to predict enrollment and identify potential challenges


Age-related macular degeneration
Dry eye
Diabetic macular edema
Retinal vein occlusion